Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Research

Mayo Clinic researchers in neuroregeneration and neurorehabilitation and other areas study causes, genetics, new diagnostic tests and treatments for neuromyelitis optica and related conditions.

Ravulizumab (Ultomiris) is currently in trials to treat NMO.

Staff in the Center for Multiple Sclerosis and Autoimmune Neurology conducts research in neuromyelitis optica, multiple sclerosis and related conditions.

Mayo Clinic researchers discovered an autoantibody, later known as aquaporin-4 antibody, which is a specific marker for NMO. Testing for this autoantibody can help diagnose NMO at an early stage and distinguish it from multiple sclerosis (MS) and other conditions.

Publications

See a list of publications about neuromyelitis optica by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Nov. 23, 2022

Related

Associated Procedures